Paolisso P., et al,  Journal of the American Society of Echocardiography, Published: January 04, 2023DOI:https://doi.org/10.1016/j.echo.2022.12.022 Background The echocardiographic parameters required for a comprehensive assessment of cardiac masses (CMs) are still largely unknown. Objectives To identify and integrate the echocardiographic features of CMs that can accurately predict malignancy. Methods Observational cohort

Ref:  Nishiura N., et al, J Am Heart Assoc. 2023;12:e025751. DOI: 10.1161/JAHA.122.025751 BACKGROUND: The natural history and optimal interventional timing in patients with isolated severe tricuspid regurgitation (TR) have not been well studied. This study aimed to investigate long-term clinical outcomes and risk factors associated with poor prognosis in patients

cardiology today, 7th Jan 2023, Adapted from Arutyunov GP, et al. ESC Heart Fail. 2022; doi:10.1002/ehf2.14243. Hospitalized patients with COVID-19 who have a history of chronic HF are at an increased risk for all-cause mortality, according to a study published in ESC Heart Failure. “Advanced chronic HF (NYHA classes III and IV) is

cardiology today, 8th Jan 2023 Adapted from: Tilly MJ, et al. Europace. 2022;doi:10.1093/europace/euac244 Autoimmune disorders were associated with elevated atrial fibrillation risk, particularly in women, according to a study published in EP Europace. Using UK Biobank data from 2006 to 2022, 494,072 patients without AF (median age, 58 years; 55% women) were analyzed

Aaqib M., et al,  American Journal of Therapeutics 29(3):p e322-e333, May/June 2022. | DOI: 10.1097/MJT.0000000000000925. Background:  Sacubitril/valsartan (LCZ696) has progressed to be one of the most promising medication since its approval for chronic heart failure with reduced ejection fraction. Recent data have suggested a superior blood pressure control with LCZ696. Data Sources:  Randomized controlled

1.Carvalho P. et al, Clinical Research in Cardiology, Received: 22 September 2022 / Accepted: 21 December 2022 , Published online 2 Jan 2023, https://doi.org/10.1007/s00392-022-02148-2 2. Braunwald E., SGLT2 inhibitors: the statins of the 21st century, European Heart Journal (2022) 43, 1029–1030, https://doi.org/10.1093/eurheartj/ehab765 Background We sought to compare cardiovascular outcomes, renal

Daniel Vari etal., Pediatric Cardiology (2022) on Published: 22 October 2022 Supraventricular tachycardia (SVT) is the most common arrhythmia in infants. Once diagnosed, infants are admitted for antiarrhythmic therapy and discharged after observation. There are limited data on risk factors for readmission and readmission rates, while on medication. The objective of this

Gechu Shang etal., Heart and Vessels (2022), Published on 01 November 2022 Blood potassium levels are associated with adverse outcomes in patients with congestive heart failure (HF). However, it is unclear whether there are differences in outcome events in elderly patients with different blood potassium levels at the time of emergency readmission

Ref: Satit Janwanishstaporn, JACC Heart Fail. 2022 Jan;10(1):27-37.  doi: 10.1016/j.jchf.2021.08.007. Epub 2021 Nov 10. Introduction Patients with reduced ejection fraction (EF) often show improvement in left ventricular EF (LVEF). Patients having LVEF increases by an absolute amount of 10% or ≥40% from a baseline <40% are referred to as having heart failure

Introduction Several clinical trials have demonstrated the superiority of angiotensin receptor-neprilysin inhibitor (ARNI) over angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) in patients with heart failure with reduced ejection fraction (HFrEF). Nevertheless, there is a dearth of evidence with respect to the long-term benefits of ARNI over ACEI

Smart, Dissolving Pacemaker Communicates With Body-Area Sensor and Control Network Northwestern University scientists introduced the first-ever transient pacemaker — a fully implantable, wireless device that harmlessly dissolves in the body after it’s no longer needed. The work was led by Northwestern’s John Rogers, PhD, the Louis Simpson and Kimberly Querrey

Introduction: Coronary artery disease (CAD) continues to be a leading cause of death and arterial hypertension is one of the major risk factor for CAD development and progression. Non-invasive diagnosis of coronary artery disease in hypertension, however, remains a major clinical challenge2 Early and effective identification and treatment of CAD